TickerKhojComparison · NSE · data 2026-11-03
Mono Pharmacare Limited vs QMS Medical Allied Services Limited
In plain words
Size: QMS Medical Allied Services Limited is about 21.5 times the market value of Mono Pharmacare Limited.
Valuation (P/E): Mono Pharmacare Limited 46.1 vs QMS Medical Allied Services Limited 30.1.
Return on equity: QMS Medical Allied Services Limited 10.5% vs Mono Pharmacare Limited 2.3%.
Profit growth over 3 years: QMS Medical Allied Services Limited 49.4% a year vs Mono Pharmacare Limited 1.5% a year.
Debt to equity: Mono Pharmacare Limited 1.77 vs QMS Medical Allied Services Limited 0.71.
Differences in the numbers, not a recommendation of either stock.
Side by side
| MONOPHARMA | QMSMEDI | |
|---|---|---|
| Price | ₹9.2 | ₹172.12 |
| Market cap | ₹16 cr | ₹350 cr |
| P/E | 46.1 | 30.1 |
| P/B | 0.5 | — |
| ROE | 2.3% | 10.5% |
| ROCE | 7.6% | 18.9% |
| Debt / equity | 1.77 | 0.71 |
| Operating margin | 2.3% | 12.7% |
| Dividend yield | 0.00% | 0.28% |
| Sales growth, 3 years (yearly) | 83.1% | 49.3% |
| Profit growth, 3 years (yearly) | 1.5% | 49.4% |
| 1-year return | -53.2% | 58.0% |
| Revenue, last 12 months | ₹166 cr | ₹183 cr |
| Net profit, last 12 months | ₹0 cr | ₹11 cr |
| Latest quarter | — | Jun 2026 |
| Quarter net profit | — | ₹4 cr |
| Quarter profit vs a year earlier | — | -42.2% |
| Promoter holding | — | 68.11% |
| Health check | Weak (3.2/10) | Strong (7.8/10) |
Common questions
Which has a higher P/E, Mono Pharmacare Limited or QMS Medical Allied Services Limited?
Mono Pharmacare Limited trades at the higher P/E (46.1 against 30.1). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
QMS Medical Allied Services Limited (10.5% against 2.3%).
Which carries more debt?
Mono Pharmacare Limited has the higher debt-to-equity ratio (1.77 against 0.71).